PRECISION MEDICINE HEALTHCARE
Clinical Decision Support for Healthcare Professionals
RISK
Is the patient likely to develop this disease?
PREVENTION
What can be done to reduce the likelihood of developing it?
DIAGNOSIS
Does the patient have the disease now?
TREATMENT
Which therapeutic pathways would be best for this patient?
PRECISION CARDIOLOGY
351
Drug profiles for cardiovascular disease treatments
The use of a patient's genetic information to determine risk, prevention, diagnosis and treatment.
Our platform is the enabler of Precision Cardiology.
240
Genes associated with cardiac disease including over 40 genes related to Stroke
20
Cardiac diseases diagnosed and managed in the platform
5
Clinical risk scoring models
THE
PLATFORM
Heart disease has many contributing factors. Our approach uses the many aspects of patient health and the complex interactions of these factors to assess patient risk, guide prevention, diagnose, treat and manage heart disease and stroke. Biosignals Diagnostics is developing a specialised comprehensive platform for this purpose. By incorporating data from the many lifestyle and biologic factors that drive these diseases, our approach delivers richer decision support for clinical diagnostic and treatment sequencing. The rich data in our platform becomes a high-value asset in its own right and can be used as a clinical resource, or in pharmaceutical development. It also enables development of our
proprietary “cardio-genetic signatures” which will bring greater clarity in the deepening relationship between genetics and heart disease. The platform architecture accommodates many data sources from consumer technologies such as phones and watches in addition to medical diagnostics data from imaging, bio-markers, genomics, ECG, blood pressure and oxygen levels. One of our key platform differentiators however is the intelligent clinical learning engine.